The size of the Single-use Bioprocessing Market in the APAC region was worth USD 0.99 Billion in 2021. It is further estimated to be growing at a CAGR of 17.8% and worth USD 2.24 billion by 2026.
Single-use bioprocessing technology is a growing technology that involves manufacturing disposable bioprocessing products and accessories for making biopharmaceutical products. Bioprocess involves the utilization of living cells or their components such as enzymes, bacteria, and others for the preferred products. The major motive behind the use of a single-use bioprocessing technique in the bioprocess is to decrease the expenditure on complicated steps such as cleaning, sterilization, and maintaining steel-based bioreactor systems. The market is showing huge growth potential in the forecasting period and is predicted to grow in the years that follow.
Improving R & D activities, growing popularity of disposable biopharmaceuticals, high spending ability of the region, increasing skill base and technological development in the bioprocessing systems is driving the growth of Asia Pacific single-use bioprocessing systems market.
However, possible environmental and economic hazards, as well as government restrictions, are the major factors restricting the growth of the single-use bioprocessing market.
This research report segmented and sub-segmented the Asia Pacific Single-use Bioprocessing Market into the following categories:
By Product:
By Application:
By Country:
Leading companies in the Asia Pacific Single-use Bioprocessing Market Profiled in the Report are Thermo Fisher Scientific, Danaher Corporation, GE Healthcare (General Electric Company), Sartorius Stedim Biotech S.A, Merck Millipore (Merck Group), 3M Company, Eppendorf AG, Finesse Solutions, Inc., Applikon Biotechnology B.V., and Cesco Bioengineering Co., Ltd.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Media Bags and Containers
5.1.3 Filtration Assemblies
5.1.4 Single use bio-reactors
5.1.5 Disposable Mixers
5.1.6 Others
5.1.7 Y-o-Y Growth Analysis, By Product
5.1.8 Market Attractiveness Analysis, By Product
5.1.9 Market Share Analysis, By Product
5.2 Application
5.2.1 Introduction
5.2.2 Filtration
5.2.3 Storage
5.2.4 Cell Culture
5.2.5 Mixing
5.2.6 Purification
5.2.7 Y-o-Y Growth Analysis, By Application
5.2.8 Market Attractiveness Analysis, By Application
5.2.9 Market Share Analysis, By Application
5.3 End User
5.3.1 Introduction
5.3.2 Research and Development Institutes
5.3.3 Biopharmaceutical Manufacturers
5.3.4 Y-o-Y Growth Analysis, By End User
5.3.5 Market Attractiveness Analysis, By End User
5.3.6 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Application
6.1.3.4 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Application
6.1.4.4 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Application
6.1.5.4 By End User
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Thermo Fisher Scientific
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Danaher Corporation
8.3 GE Healthcare
8.4 Sartorius Stedim Biotech S.A
8.5 Merck Millipore
8.6 3M Company
8.7 Eppendorf AG
8.8 Finesse Solutions
8.9 Cytori Therapeutics
8.10 Cesco Bioengineering Co.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
